基础医学与临床 ›› 2025, Vol. 45 ›› Issue (10): 1318-1325.doi: 10.16352/j.issn.1001-6325.2025.10.1318

• 研究论文 • 上一篇    下一篇

METTL3通过介导TRPM7甲基化调节宫颈癌细胞铁死亡和恶性进展

付淼*, 刘蓬, 田文, 王莎, 尹晓梅, 刘昊, 王东海   

  1. 保定市第二中心医院 妇产科,河北 保定 072750
  • 收稿日期:2024-08-15 修回日期:2024-11-22 出版日期:2025-10-05 发布日期:2025-09-22
  • 通讯作者: *fumhbbd@163.com
  • 基金资助:
    保定市科技计划项目(2241ZF195)

METTL3 regulates ferroptosis and malignant progression of cervical cancer cells through mediating TRPM7 methylation

FU Miao*, LIU Peng, TIAN Wen, WANG Sha, YIN Xiaomei, LIU Hao, WANG Donghai   

  1. Department of Gynecology and Obstetrics, the Second Central Hospital of Baoding, Baoding 072750, China
  • Received:2024-08-15 Revised:2024-11-22 Online:2025-10-05 Published:2025-09-22
  • Contact: *fumhbbd@163.com

摘要: 目的 探讨甲基转移酶3(METTL3)介导的N6-甲基腺苷(m6A)甲基化修饰的瞬时受体电位阳离子通道亚家族M成员7(TRPM7)调节宫颈癌(CESC)铁死亡和恶性进展的分子生物学机制。方法 选取30例CESC患者,术中收集CESC组织和邻近癌旁组织(距肿瘤组织边缘≥3 cm),分为试验组和对照组。RT-qPCR和Western blot检测两组TRPM7 mRNA和蛋白表达差异。构建TRPM7干扰细胞株,检测TRPM7对CESC细胞的作用。采用5-乙酰基-2-脱氧尿嘧啶核苷(EdU)和流式细胞测量术检测CESC细胞增殖和凋亡;Transwell小室法检测细胞侵袭和迁移能力;分别采用活性氧(ROS)、丙二醛(MDA)、谷胱甘肽(GSH)和Fe2+试剂盒检测CESC细胞铁死亡水平;生物信息学预测TRPM7的相关甲基化酶;RNA结合蛋白免疫共沉淀(RIP)和RNA甲基化免疫共沉淀实时定量PCR(Me-RIP qPCR)检测METTL3与TRPM7的相互作用关系;放线菌素D检测METTL3对TRPM7表达稳定性影响。结果 TRPM7在CESC组织和细胞中高表达。干扰TRPM7基因表达显著抑制CESC细胞增殖、促进细胞凋亡、抑制细胞迁移、侵袭能力、促进细胞铁死亡水平(P<0.05)。生物信息学预测METTL3可能为TRPM7的甲基化酶,干扰METTL3基因显著降低TRPM7蛋白水平,降低TRPM7 m6A水平,并降低TRPM7基因的稳定性(P<0.05)。结论 METTL3甲基化修饰TRPM7基因调控CESC增殖、凋亡、迁移、侵袭和铁死亡。

关键词: 宫颈癌, 瞬时受体电位阳离子通道亚家族M成员7, 甲基转移酶3, 铁死亡, N6-甲基腺苷

Abstract: Objective Methyltransferase 3(METTL3) mediated N6-methyladenosine (m6A) methylation modifica-tion of transient receptor potential cation channel subfamily M member 7(TRPM7) regulates ferroptosis and malignant progression in cervical cancer(CESC). Methods Totally 40 patients with cervical cancer were collected. Cervical cancer tissues and adjacent normal tissues(≥3 cm from the edge of the tumor tissue) were sampled at operation and then divided into experimental group and control group, respectively. RT-qPCR and Western blot were used to detect the differences in TRPM7 mRNA and protein expression between the two groups. TRPM7-interfering cell lines were constructed to investigate the effects of TRPM7 on CESC cells. Cell proliferation and apoptosis were assessed using 5-ethynyl-2'-deoxyuridine (EdU) assay and flow cytometry, respectively. Transwell chamber assays were employed to evaluate cell invasion and migration capabilities. The levels of ferroptosis in CESC cells were measured using kits for reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), and Fe2+. Bioinformatics tools were utilized to predict methyltransferases associated with TRPM7. The interaction between METTL3 and TRPM7 was examined through RNA immunoprecipitation (RIP) and methylated RNA immunoprecipitation quantitative PCR (Me-RIP qPCR). The effect of METTL3 on the stability of TRPM7 expression was assessed using actinomycin D assay. Results TRPM7 was highly expressed in CESC tissue and cells. Knockdown of TRPM7 significantly inhibited cell proliferation, promoted cell apoptosis, suppressed cell migration and invasion capabilities, and enhanced ferroptosis levels (P<0.05). Bioinformatics predictions suggested that METTL3 might act as a methyltransferase for TRPM7. Interference with METTL3 gene expression significantly reduced TRPM7 protein levels, decreased TRPM7 m6A modification levels, and impaired TRPM7 gene stability (P<0.05). Conclusions METTL3 regulates CESC proliferation, apoptosis, migration, invasion, and ferroptosis by m6A methylation modification of the TRPM7 gene.

Key words: cervical squamous cell carcinoma, transient receptor potential cation channel subfamily M member 7, methyltransferase 3, ferroptosis, N6-methyladenosine

中图分类号: